Life Sciences Funding Opportunities

    Last updated: 11/20/18. For additional funding resources, please see available funding on the EVPRP website


    Purdue Institute for Integrative Neuroscience

    Funding Opportunity

    Award Amount

    Deadline

    Indiana CTSI Predoctoral Training Award

    Varies

    November 15, 2018

    NIH Neuromodulation/Neurostimulation Device Development for Mental Health Applications R01 and R21

    Varies

    November 26, 2018

    NSF Emerging Frontiers in Research and Innovation 2019 (EFRI-2019) (LOI)

    $30,000,000

    November 29, 2018

    NIH Exploratory Grant for NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20) (LOI)

    Varies

    December 4, 2018

    Burkhart Excellence in Research Award

    $500

    December 5, 2018

    NSF Accelerating Research through International Network-to-Network Collaborations (LOI)

    Varies

    December 21, 2018

    NIH Early Screening for Autism Spectrum Disorder R01 and R21 (LOI)

    Varies

    January 4, 2019

    NIH Exploratory Grant for NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20) (Application)

    Varies

    January 4, 2019

    NSF Emerging Frontiers in Research and Innovation 2019 (EFRI-2019) (Preproposal)

    $30,000,000

    January 7, 2019

    Brain Research Foundation--Fay/Frank Seed Grant Program

    $80,000

    January 8, 2019

    NIH Promoting Research on Music and Health: Fundamentals and Applications R01, R21 and R61/33 (LOI)

    Varies

    January 15, 2019

    NSF Joint DMS/NLM Initiative on Generalizable Data Science Methods for Biomedical Research (DMS/NLM)

    $600,000 - $900,000

    January 16, 2019

    NIH Early Screening for Autism Spectrum Disorder R01 and R21

    Varies

    February 4, 2019

    NIH Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain R01 and R21

    Varies

    R01: February 5, 2019
    R21: February 16, 2019

    NIH Biobehavioral Basis of Chronic Pain R01 and R21

    Varies

    R01: February 5, 2019
    R21: February 16, 2019

    NIH Clarifying the Relationship between Delirium and Alzheimer’s Disease and Related Dementias R01 and R21/R33

    Varies

    R01: February 5, 2019
    R21/R33: February 16, 2019

    NIH Comparative Genomics Research Program (R01)

    Varies

    February 5, 2019

    NIH New Onset Depressive Symptoms in Acute Illness R01 and R21

    Varies

    R01: February 5, 2019
    R21: February 16, 2019

    NIH Research on Chronic Overlapping Pain Conditions R01 and R21

    Varies

    R01: February 5, 2019
    R21: February 16, 2019

    Klingenstein-Simons Fellowship Awards in Neuroscience

    $225,000

    February 15, 2019

    CART Fund Alzheimer’s Research (Full Application)

    $250,000

    February 22, 2019

    NSF Accelerating Research through International Network-to-Network Collaborations (Full Proposal)

    Varies

    February 28, 2019

    NIH Promoting Research on Music and Health: Fundamentals and Applications R01, R21 and R61/33 (Application)

    Varies

    February 28, 2019

    NSF Emerging Frontiers in Research and Innovation 2019 (EFRI-2019) (Full Proposal)

    $30,000,000

    April 25, 2019

    CART Fund Alzheimer’s Research (LOI)

    $250,000

    December 3, 2018

    Purdue Institute of Inflammation, Immunology and Infectious Disease

    Funding Opportunity

    Award Amount

    Deadline

    NIH Notice of Intent to Publish Funding Opportunity Announcements to Promoter Implementation Science (R01) and Dissemination and Implementation Studies (R18)

    Varies

    Calendar Year

    Alfred P. Sloan Foundation

    Varies

    On-going

    NIH-NIAID Omnibus Broad Agency Announcement

    Varies

    Varies

    Immune Epitope and Analysis Resource Program

    Varies

    Varies

    Trophoblast Differentiation and Function (R21 Clinical Trial Optional)

    Varies

    Varies

    ORAU Higher Education Research Experiences for Faculty at Oak Ridge National Laboratory

    Varies

    On-going

    NSF Ecology and Evolution of Infectious Diseases (EEID)

    Varies

    November 21, 2018

    NIH Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01)

    Varies

    November 27, 2018

    NIH Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21)

    Varies

    November 27, 2018

    DOD-Army Deployed Warfighter Protection Program Research Opportunities

    $4,500,000

    November 30, 2018

    Purdue Women’s Global Health Institute (WGHI) and Indiana Clinical and Translational Sciences Institute (CTSI) Women's Health Research Pilot Grant

    $30,000 for two awards

    November 30, 2018

    NIH Engaging Men in HIV Testing, Prevention, and Care
    R01
    R21

    Varies

    January 7, 2019

    HHS-FDA Natural History Studies Addressing Unmet Needs of Rare Diseases: Orphan Products Research Project Grant (R01)

    Varies

    January 10, 2019

    NIH Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R01)

    Varies

    January 11, 2019

    NIH Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21)

    Varies

    January 14, 2019

    Collections in Support of Biological Research (CSBR)

    Varies

    January 29, 2019

    Instrument Capacity for Biological Research (ICBR)

    Varies

    January 29, 2019

    Infrastructure Innovation for Biological Research (IIBR)

    Varies

    January 29, 2019

    NIH Fc-Dependent Mechanisms of Antibody-Mediated Killing
    U01
    R21

    Varies

    February 1, 2019
    February 16, 2019

    NIH Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB)
    R01
    R18

    Varies

    February 5, 2019
    January 25, 2019

    NIH Processing and Presentation of Non-Conventional MHC Ligands
    R01
    R21

    Varies

    February 5, 2019
    February 16, 2019

    NIH Immuno-Oncology Translational Network (IOTN)

    Varies

    February 8, 2019
    February 8, 2019
    February 11, 2019

    February 11, 2019

    NIH Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)

    Varies

    February 11, 2019

    NIH Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21)

    Varies

    February 16, 2019

    NIH Single-Cell Multi-Omics of HIV Persistence (R01)

    Varies

    March 13, 2019

    NIH Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)

    Varies

    May 7, 2019

    NIH Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18)

    Varies

    July 12, 2019

    HHS Office of Biomedical Advanced Research and Development Authority (BARDA) BAA

    Varies

    October 31, 2019

    DOD-CDMRP BAA for Extramural Biomedical Research and Development

    Varies

    On-going through July 31, 2023

    Purdue Institute for Drug Discovery

    Funding Opportunity

    Award Amount

    Deadline

    Antibacterial Resistance Leadership Group (ARLG) Collaboration

    Varies

    Rolling

    Alpha-Synuclein Imaging Prize

    2,000,000

    Rolling

    Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21)

    $275,000

    November 27, 2018

    Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33)

    Varies

    November 27, 2018

    Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01)

    Varies

    November 27, 2018

    NIH Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment  (R01)

    Varies

    November 27, 2018

    NIH Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21)

    $275,000

    November 27, 2018

    NIH Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33)

    Varies

    November 27, 2018

    Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33)

    Varies

    November 27, 2018

    NIH Sustained Release Innovation for HIV (SRI) (R61/R33)

    Varies

    November 30, 2018

    CART Fund Alzheimer’s Research  

    Varies

    LOI December 3, 2018

    NIH HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01)  

    Varies

    December 5, 2018

    NIH Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01)

    Varies

    December 13, 2018

    NSF Understanding the Rules of Life: Building a Synthetic Cell  

    Varies

    Preliminary Proposal
    December 28, 2018

    NIH Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3)

    Varies

    January 4, 2019

    NIH Exploratory Grant for NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20)

    $250,000

    January 4, 2019

    CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)

    Varies

    January 7, 2019

    NIH Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R01)

    Varies

    January 11, 2019

    NIH Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21)

    $275,000

    January 14, 2019

    NIH Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB)   (R18)

    Varies

    January 25, 2019

    NIH Fc-Dependent Mechanisms of Antibody-Mediated Killing  (U01)

    $300,000

    February 1, 2019

    NSF Understanding the Rules of Life: Epigenetics  

    Varies

    February 1, 2019

    NIH Alzheimer Centers for Discovery of New Medicines (U54)

    Varies

    February 1, 2019

    Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)

    $2,500,00

    February 5, 2019

    First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)

    Varies

    February 5, 2019

    Drug Discovery For Nervous System Disorders (R01)

    Varies

    February 5, 2019

    Promoting Research in Basic Neuroscience (R01)

    Varies

    February 5, 2019

    Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)

    Varies

    February 5, 2019

    NIH Processing and Presentation of Non-Conventional MHC Ligands  (R01)

    Varies

    February 5, 2019

    NIH Comparative Genomics Research Program (R01)

    Varies

    February 5, 2019

    NIH Applying Metabolomics to Drive Biomarker Discovery in Symptom Science   (R01)

    Varies

    February 5, 2019

    NIH Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R01)

    Varies

    February 5, 2019

    NIH Innovative Questions in Symptom Science and Genomics

    Varies

    February 5, 2019

    NIH Radiation Biodosimetry Assays and Devices (U01)  

    Varies

    February 11, 2019

    NIH Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)  

    Varies

    February 11, 2019

    CREATE Bio Optimization Track for Biologics (U01)

    Varies

    February 13, 2019

    NIH Innovative Questions in Symptom Science and Genomics

    Varies

    February 16, 2019

    NIH Applying Metabolomics to Drive Biomarker Discovery in Symptom Science  (R21)

    $275,000

    February 16, 2019

    NIH Fc-Dependent Mechanisms of Antibody-Mediated Killing  (R21)

    $275,000

    February 16, 2019

    NIH Processing and Presentation of Non-Conventional MHC Ligands  (R21)

    $275,000

    February 19, 2019

    CREATE Bio Development Track: Nonclinical and Early-Phase Clinical Development for Biologics (U44)

    $6,500,000

    February 20, 2019

    Camille and Henry Dreyfus Foundation’s 2019 Dreyfus Prize in the Chemical Sciences  

    $250,000

    February 28, 2019

    NIH Single-Cell Multi-Omics of HIV Persistence (R01)  

    Varies

    March 13, 2019

    NIH Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01)

    Varies

    March 14, 2019

    NIH Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)

    Varies

    May 7, 2019

    Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)

    Varies

    June 25, 2019

    Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)

    $300,000

    September 10, 2019

    Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)

    Varies

    September 10, 2019

    Purdue University Institute for Plant Sciences

    Funding Opportunity

    Award Amount

    Deadline

    Specialty Crop Research Initiative (SCRI)

    $80,000,000

    December 10, 2018

    Purdue Center for Cancer Research

    Funding Opportunity

    Deadline

    NIH Funding Opportunities

    NIH Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24)

    November 19, 2018

    NIH Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia The goal of this FOA is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings from such research are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS, and may provide insight into novel targets for interventions that might alleviate some burden associated with these symptoms or suggest strategies for prevention of the development of NPS as related to AD or ADRD.
    R01
    R21

    November 19, 2018

    NIH Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33)

    November 27, 2018

    NIH Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability.
    R01
    R21

    November 27, 2018

    NIH Pediatric Immunotherapy Discovery and Development Network (PI-DDN)
    U01 Deadline: December 17
    U54 Deadline: December 17

    December 17, 2018

    NIH Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3)

    January 4, 2019

    NIH Improving Smoking Cessation Interventions among People Living with HIV
    R01
      R21

    January 8, 2019

    NIH Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01)

    January 9, 2019

    NIH-NCI Research Specialist (Laboratory-based Scientist) Award (R50)

    January 11, 2019

    NIH-NCI Research Specialist (Core-based Scientist) Award (R50)

    January 11, 2019

    NIH Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)

    February 11, 2019

    NIH Immuno-Oncology Translational Network (IOTN) These FOAs are associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research.
    · Cancer Immunotherapy Research Projects (U01) The purpose of this FOA is to expand organ site-specific Cancer Immunotherapy Research Projects as components of the Immuno-Oncology Translation Network (IOTN). Deadline: February 8
    · Cancer Immunoprevention Research Projects (U01) The purpose of this specific FOA is to expand Cancer Immunoprevention Research Projects as components of the Immuno-Oncology Translation Network (IOTN). Deadline: February 8
    · Cancer Immunoprevention Research Projects (UG3/UH3) Deadline: February 11
    · Immuno-engineering to Improve Immunotherapy (i3) Centers (U54) Deadline: February 11

    Varies

    NIH Applying a Biopsychosocial Perspective to Self-Management of Chronic PainThe purpose of the Funding Opportunity announcement is to encourage grant applications from the scientific community on applying a biopsychosocial perspective to self-management of chronic pain. Interdisciplinary collaborations that include nurse scientists in the project team are strongly encouraged.
    R01 Deadline: February 5
    R21 Deadline: February 16

    Varies

    NIH Biobehavioral Basis of Chronic Pain The purpose of the Funding Opportunity Announcement is to encourage grant applications from the scientific community on the biobehavioral basis of chronic pain. The focus encompasses the individual phenotype, genotype, and other omic-type assessments and the associated sensory and emotional components that underpin the individual’s chronic pain experience. Research relating biology and behavior is needed to better define the individual-specific burden of chronic pain and to better understand the mechanisms underlying differences in pain experiences among individuals afflicted with the same chronic illness.
    R01 Deadline: February 5
    R21 Deadline: February 16

    NIH Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors This initiative will support exploratory and developmental multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.
    R01 Deadline: March 4
    R21 Deadline: March 4

    March 4, 2018

    NIH Notice of Intent to Publish a FOA for Diversity Program Consortium Dissemination and Translation Awards (U01)

    July 1, 2020

    NIH Administrative Supplements to Existing NIH Grants and Cooperative Agreements. The National Institutes of Health (NIH) hereby notify Program Directors/Principal Investigators (PD(s)/PI(s)) holding specific types of NIH research grants listed in the full Funding Opportunity Announcement (FOA) that funds may be available for administrative supplements to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.

    Varies by awarding IC

    Other Cancer Funding Opportunities

    Funding Opportunity

    Deadline

    NSF Emerging Frontiers in Research and Innovation 2019 (EFRI-2019) This solicitation is a funding opportunity for interdisciplinary teams of researchers to embark on rapidly advancing frontiers of fundamental engineering research. NSF will consider proposals under two research areas: 1) Chromatin and Epigenetic Engineering (CEE), and 2) Continuum, Compliant, and Configurable Soft Robotics Engineering (C3 SoRo). EFRI seeks proposals with transformative ideas that represent an opportunity for a significant shift in fundamental engineering knowledge with a strong potential for long term impact on national needs or a grand challenge.

    Deadlines: November 29 – LOI;

    January 7 – Preliminary proposal;

    April 25 – Full proposal

    Global Grants for Gut Health—co-sponsored by Nature Research and Yakult Honsha Co. Ltd.
    *Application details attached as PDF to this email
    Application deadline: November 30, 2018
    Amount: up to $100,000 over one year
    Applicant restrictions: Applicants must have at least five years’ postdoctoral research experience.
    Description: The Global Grants for Gut Health is a competitive programme for investigator-initiated research into the human gut microbiota, supported by Yakult and Nature Research. The Global Grants for Gut Health will consider proposals one-year for research projects – whether laboratory investigations or clinical studies – that advance understanding of the impact of the gut microbiota on human health.
    Website: https://www.guthealth-grants.com/pages/applicant-guidelines

    November 30, 2018

    Lustgarten Foundation Pancreatic Cancer Research The Pancreatic Cancer Collective (PCC) invites applications for the Pancreatic Cancer Collective – Computational Approaches to Identifying High Risk Pancreatic Cancer Populations Grant. The Team(s) will develop tools to identify individuals in the general population who are at high risk for pancreatic cancer far earlier than they would otherwise be diagnosed, using information from existing dataset(s) (such as the OptumLabs Data Warehouse*, UK Biobank*, Danish National Patient Registry*, and/or other comparable datasets).

    December 14, 2018

    The Pancreatic Cancer Action Network is excited to open two grant opportunities to further your pancreatic cancer research. The 2019 Catalyst Grant, to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in the field, and the 2019 Translational Research Grant, designed to support translational research of novel targets and approaches to the treatment of pancreatic cancer, are now accepting applications.

    2019 Catalyst Grant
    Application deadline: December 7, 2018

    2019 Translational Research Grant
    Application deadline: December 21, 2018

    Varies

    Brain Research Foundation--Fay/Frank Seed Grant Program
    *RFP attached as PDF to this email
    Application deadline: January 8, 2019
    Amount: up to $80,000 over two years
    Limitations: U.S. institutions may only nominate one faculty member to submit an LOI
    Description: The purpose of the Program is to provide start-up monies for new research projects in the field of neuroscience that will likely lead to extramural funding from the National Institutes of Health (NIH) or other outside funding sources. The objective of the program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions. BRF Seed Grant awards are not intended to supplement existing grants. The area of studies is brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease.
    Website: https://www.thebrf.org/for-researchers/fayfrank-seed-grant-program/
    Previous recipients: https://www.thebrf.org/what-we-do/fayfrank-seed-grants/

    January 8, 2019

    Burroughs Wellcome Fund – Innovation in Regulatory Science Awards
    *RFP with detailed information attached to this email
    Application deadline: February 6, 2019
    Amount: $500,000 over 5 years
    Description: This initiative is designed to provide financial support to stimulate research efforts in innovative regulatory science. The program's focus is on providing support for academic researchers developing new methodologies or innovative approaches in regulatory science that will ultimately inform the regulatory decisions FDA and others make. This would necessarily draw upon the talents of individuals trained in mathematics, computer science, applied physics, medicine, engineering, toxicology, epidemiology, biostatistics, and systems pharmacology, to name a few.
    Website: https://www.bwfund.org/grant-programs/regulatory-science/innovation-regulatory-science
    Previous recipients: https://www.bwfund.org/grant-programs/regulatory-science/innovation-regulatory-science/grant-recipients

    February 6, 2019

    Klingenstein-Simons Fellowship Awards in Neuroscience
    Application deadline: February 15, 2019
    Amount: $225,000 over 3 years
    Applicant restrictions: The candidate must be within 4 years of completing postdoctoral training and the start of his/her tenure track or equivalent appointment (between July 1, 2015 and July 1, 2019).
    Description: The Klingenstein-Simons Fellowship Awards in Neuroscience supports, in the early stages of their careers, young investigators engaged in basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. The Klingenstein Fund and the Simons Foundation recognize that to accomplish this goal it is necessary to encourage a variety of new approaches. Several areas within the neurosciences are of particular interest:
    Cellular and molecular neuroscience—Studies of the mechanisms of neuronal excitability and development, and of the genetic basis of behavior.
    Neural systems—Studies of the integrative function of the nervous system.
    Translational research—Studies designed to improve the prevention, diagnosis, treatment and our understanding of the causes of neurological and psychiatric disorders.
    Website: http://www.klingfund.org/
    Previous recipients: http://www.klingfund.org/fellows/fellows18.php

    February 15, 2019

    Camille and Henry Dreyfus Foundation’s 2019 Dreyfus Prize in the Chemical Sciences The Dreyfus Prize, awarded biennially, recognizes an individual for exceptional and original research in a selected area of chemistry that has advanced the field in a major way. The prize consists of a monetary award of $250,000, a medal, and a certificate. This year’s theme is Chemistry in Support of Human Health. Any person may nominate a candidate for the Dreyfus Prize. Self-nominations are not accepted.

    February 28, 2019

    NSF Biophotonics

    On-going through August 15, 2019

    NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)

    On-going

    NSF Big Ideas updates

    Varies

    DOD-CDMRP Ovarian Cancer Research Program (OCRP)

    Deadlines vary by program area

    DOD-CDMRP Lung Cancer

    Varies

    DOD-CDMRP Prostate Cancer

    Varies

    DOD-CDMRP Peer Reviewed Cancer Research Program

    Varies

    DOD-CDMRP Peer Reviewed Medical Research Program The program includes several mechanisms including: Discovery Award; Focused Program Award; Investigator-Initiated Research Award, and Technology/Therapeutic Development Award.

    Varies

    The AACR is currently accepting applications for the following opportunities:
    Grants for mentored researchers in the areas of lung, ovarian, pediatric, and breast cancer research, lymphoma, myeloma, and all areas of clinical and translational cancer research
    A grant for tenure-eligible junior faculty focused on any area of cancer research
    A grant for established investigators in the field of neuroendocrine tumor research
    Learn More
    Apply Now

    Varies

    Limited Submissions
    Purdue Internal Deadlines for Proposals
    Numerous new opportunities, follow link for details

    Varies

    Purdue University, West Lafayette, IN 47907 (765) 494-4600

    © 2018 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by Office of the Executive Vice President for Research and Partnerships

    If you have trouble accessing this page because of a disability, please contact Office of the Executive Vice President for Research and Partnerships at evprp@purdue.edu.